Live attenuated MMR/V booster vaccines in children with rheumatic diseases on immunosuppressive therapy are safe: Multicenter, retrospective data collection

Juvenile Idiopathic Arthritis

Safety of biological agents in paediatric rheumatic diseases: a real-life multicenter retrospective study using the JIRcohorte database

Joint Bone Spine.

Cabrera N, Lega JC, Kassai B, Wouters C, Kondi A, Cannizzaro E, Woerner A, Chausset A, Roethlisberger S, Jeanneret C, Aeschlimann F, Malik S, Duquesne A, Kaiser D, Higel L, Maes A, Berthet G, Hentgen V, Kone-Paut I, Belot A, Hofer M

doi: 10.1016/j.jbspin.2018.08.003.

Autoimmune Disease

Effectiveness of inactivated influenza vaccine in autoimmune rheumatic diseases treated with disease-modifying anti-rheumatic drugs

Rheumatology (Oxford).

Nakafero G, Grainge MJ, Myles PR, Mallen CD, Zhang W, Doherty M, Nguyen-Van-Tam JS, Abhishek A

doi: 10.1093/rheumatology/keaa078.

Psoriatic ArthritisRheumatoid ArthritisSpinal Disorders

Safety and immunogenicity of tetanus/diphtheria vaccination in patients with rheumatic diseases-a prospective multi-centre cohort study

Rheumatology (Oxford).

Bühler S, Jaeger VK, Adler S, Bannert B, Brümmerhoff C, Ciurea A, Distler O, Franz J, Gabay C, Hagenbuch N, Herzog C, Hasler P, Kling K, Kyburz D, Müller R, Nissen MJ, Siegrist CA, Villiger PM, Walker UA, Hatz C

doi: 10.1093/rheumatology/kez045.

Further Publications Rheumatology

Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey

RMD Open

Sattui SE, Liew JW, Kennedy K, Sirotich E, Putman M, Moni TT, Akpabio A, Alpízar-Rodríguez D, Berenbaum F, Bulina I, Conway R, Singh AD, Duff E, Durrant KL, Gheita TA, Hill CL, Howard RA, Hoyer BF, Hsieh E, El Kibbi L, Kilian A, Kim AH, Liew DFL, Lo C, Miller B, Mingolla S, Nudel M, Palmerlee CA, Singh JA, Singh N, Ugarte-Gil MF, Wallace J, Young KJ, Bhana S, Costello W, Grainger R, Machado PM, Robinson PC, Sufka P, Wallace ZS, Yazdany J, Harrison C, Larché M, Levine M, Foster G, Thabane L, Rider LG, Hausmann JS, Simard JF, Sparks JA

doi: 10.1136/rmdopen-2021-001814

Immune Response

Long-term immunogenicity after yellow fever vaccination in immunosuppressed and healthy individuals

Vaccine.

Burkhard J, Ciurea A, Gabay C, Hasler P, Müller R, Niedrig M, Fehr J, Villiger P, Visser LG, de Visser AW, Walker UA, Hatz C, Bühler S

doi: 10.1016/j.vaccine.2019.12.042.

Further Publications DermatologyFurther Publications ImmunologyFurther Publications Rheumatology

Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy

J Autoimmun.

Ceribelli A, Motta F, De Santis M, Ansari AA, Ridgway WM, Gershwin ME, Selmi C

doi: 10.1016/j.jaut.2020.102442.

Systemic Sclerosis

Disease frequency, patient characteristics, comorbidity outcomes and immunosuppressive therapy in systemic sclerosis and systemic sclerosis-associated interstitial lung disease: a US cohort study

Rheumatology (Oxford)

Li Q, Wallace L, Patnaik P, Alves M, Gahlemann M, Kohlbrenner V, Raabe C, Wang JR, Garry EM

doi: 10.1093/rheumatology/keaa547

EULAR ^® 2019

Further Publications DermatologyFurther Publications ImmunologyFurther Publications Rheumatology

Rheumatic and Musculoskeletal Diseases

Yusof et al. 2019. Predicting severe infection in repeat cycles of rituximab and effects of hypogammaglobulinemia for the treatment of rheumatic and musculoskeletal diseases. Oral presentation presented at: EULAR 2019 Congress; 12–15 June 2019; Madrid, Spain.

Safe and effective use of Alitretinoin in Children with recalcitrant hand eczema and other dermatoses - a retrospective analysis

J Eur Acad Dermatol Venereol.

Luchsinger I, Vogler T, Schwieger-Briel A, Knöpfel N, Wälchli R, Weibel L, Theiler M

doi: 10.1111/jdv.16088.

Related content